Relevance of genetic polymorphisms in inflammatory response to percutaneous coronary intervention

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 7, 2009, Pages 736-740

  Saleh, Nawzad ^a   Kovacs, Alexander ^a   Tornvall, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genotype; Inflammation; PCI

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INFLAMMATION; INTERLEUKIN 6 GENE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROMOTER REGION; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS; STENT; STIMULUS RESPONSE; TREATMENT RESPONSE; UPREGULATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AREA UNDER CURVE; C-REACTIVE PROTEIN; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; POLYMORPHISM, GENETIC;

EID: 74549208102     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903100466     Document Type: Article

References (18)

1. Azar RR, McKay RG, Kieman FJ, Seecharran B, Feng YJ, Fram DB, Wu AH, Waters DD. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol. 1997;80:1476-8.
2. Saleh N, Tornvall P . Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis. 2007;195:374-8.
3. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, Ghini AS, Ferrero V, Chiariello L, Gioffre PA, Romeo F, Crea F. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation. J Am Coll Cardiol. 2002;40:1935-42.
4. Ozdol C, Gulec S, Rahimov U, Atmaca Y, Turhan S, Erol C. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention. Thromb Res. 2007;119:453-9.
5. Saleh N, Svane B, Hansson L-O, Jensen J, Nilsson T, Danielsson O, Tornvall P. Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem. 2005;51:2124-30.
6. Saleh N, Svane B, Jensen J, Hansson L-O, Nordin M, Tornvall P. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and Interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J. 2005;149:876-82.
7. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, Liu K, Williams OD, Iribarren C, Lewis EC, Fomage M, Boerwinkle E, Gross M, Jaquish C, Nickerson DA, Myers RM, Siscowick DS, Reiner AP. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77:64-77.
8. Kovacs A, Green F, Hansson L-O, Lundman P, Samnegård A, Boquist S, Ericsson C-G, Watkins H, Hamsten A, Tornvall P. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with plasma concentrations of C-reactive protein. Atherosclerosis. 2005;178:193-8.
9. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:18138-44.
10. Bennermo M, Held C, Stemme S, Ericsson C-G, Silveira A, Green F, Tornvall P. Genetic predisposition to the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem. 2004;50:2136-40.
11. Ronaghi M, Uhlén M, Nyrén P. DNA sequencing: a sequencing method based on real-time pyrophosphate. Science. 1998;281:363-5.
12. Zee RYL, Hegener HH, Fernandez-Cruz A, Lindpaintner K. C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis. 2004;176:393-6.
13. Marso SP, House JA, Hopkins PJ. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G>C polymorphism and complex plaque morphology. Int J Immunogenetics. 2006;33:347-54.
14. Merino A, Gaya A, Segura I, Calvo J, Imizcoz C, Berenguel A, Alegria E. Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: effects of the -174G>C IL-6 gene polymorphism. Am J Cardiol. 2004;94:1300-3.
15. Danik JK, Ridker PM. Genetic determinants of C-reactive protein. Curr Atheroscler Rep. 2007;9:195-203.
16. Brull DJ, Serrano N, Zito F, Jonas L, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE, Hingorani AD. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23:2063-9.
17. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS. C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis. 2005;179:413-7.
18. Bennermo M, Held C, Watkins H, Green F, Hamsten A, Strandberg L-E, Ericsson C-G, Hansson L-O, Tornvall P. Prognostic value of the interleukin-6 gene -174 G>C and -572 G>C promoter polymorphism and plasma interleukin-6 levels in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis. 2004;174:157-63.